参考文献
[1]Yao K,Anagnostopoulos GK,Ragunath K.Magnifying endoscopy for diagnosing and delineating early gastric cancer[J].Endoscopy,2009,41:462-7.
[2]Yao K,Iwashita A,Tanabe H,et al.White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging:a new optical sign for differentiating between adenoma and carcinoma[J].Gastrointest Endosc,2008,68:574-80.
[3]Muto M,Yao K,Kaise M,et al.Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G)[J].Dig Endosc,2016,28:379-93.
[4]Ezoe Y,Muto M,Uedo N,et al.Magnifying narrow band imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer[J].Gastroenterology,2011,141:2017-25.e3.
[5]Yao K,Doyama H,Gotoda T,et al.Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer:a prospective multicenter feasibility study[J].Gastric Cancer,2014,17:669-79.
[6]Yamada S,Doyama H,Yao K,et al.An efficient diagnostic strategy for small,depressed early gastric cancer with magnifying narrow-band imaging:a post-hoc analysis of a prospective randomized controlled trial[J].Gastrointest Endosc,2014,79:55-63.
[7]Maki S,Yao K,Nagahama T,et al.Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions[J].Gastric Cancer 2013,16:140- 146.
[8]Miwa K,Doyama H,Ito R,et al.Can magnifying endoscopy with narrow band imaging be useful for low grade adenomas in preoperative biopsy specimens?[J]Gastric Cancer,2012,15:170-8.10.1007/s10120-011-0093-6.
[9]Fujiwara S,Yao K,Nagahama T,et al.Can we accurately diagnose minute gastric cancers (≤5 mm)? Chromoendoscopy (CE) vs magnifying endoscopy with narrow band imaging (M-NBI)[J].Gastric Cancer,2015,18:590-596.
[10]Zhang Q,Wang F,Chen ZY,et al.Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer:a meta-analysis[J].Gastric Cancer,2016,19:543-52.
[11]Dohi O,Yagi N,Majima A,et al.Diagnostic ability of magnifying endoscopy with blue laser imaging for early gastric cancer:a prospective study[J].Gastric Cancer,2017,20:297-303.
[12]Dohi O,Yagi N,Yoshida S,et al.Magnifying Blue Laser Imaging versus Magnifying Narrow-Band Imaging for the Diagnosis of Early Gastric Cancer:A Prospective,Multicenter,Comparative Study[J].Digestion,2017,96:127-134.
[13]Yoshimizu S,Yamamoto Y,Horiuchi Y,et al.Diagnostic performance of routine esophagogastroduodenoscopy using magnifying endoscope with narrow-band imaging for gastric cancer[J].Dig Endosc,2018,30:71-78.
[14]Yao K.Zoom gastroscopy:magnifying endoscopy in the stomach[J].Tokyo:Springer,2013,66-67.
[15]Yao K.The endoscopic diagnosis of early gastric cancer[J].Ann Gastroenterol,2013,26:11-22.
[16]Matsushita M,Mori S,Uchida K,et al.“White opaque substance” and “light blue crest” within gastric flat tumors or intestinal metaplasia:same or different signs? Gastrointest Endosc,2009,70:402-403.
[17]Kanemitsu T,Yao K,Nagahama T,et al.Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach:the white opaque substance marker[J].Endoscopy,2017,49:529-535.
[18]Yao K,Iwashita A,Nambu M,et al.Nature of white opaque substance in gastric epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging[J].Dig Endosc,2012,24:419-425.
[19]Ueo T,Yonemasu H,Yada N,et al.White opaque substance represents an intracytoplasmic accumulation of lipid droplets:immunohistochemical and immunoelectron microscopic investigation of 26 cases[J].Dig Endosc,2013,25:147-55.10.1111/j.1443-1661.2012.01364.x.
[20]Ueo T,Yonemasu H,Yao K,et al.Histologic differentiation and mucin phenotype in white opaque substance-positive gastric neoplasias[J].Endosc Int Open,2015,3:597-604.
[21]Song J,Zhang J,Wang J,et al.Meta-analysis:narrow band imaging for diagnosis of gastric intestinal metaplasia[J].PLoS One,2014,9:e94869.
[22]Ang TL,Fock KM,Teo EK,et al.The diagnostic utility of narrow band imaging magnifying endoscopy in clinical practice in a population with intermediate gastric cancer risk[J].Eur J Gastroenterol Hepatol,2012,24:362-367.
[23]Lage J,Pimentel-Nunes P,Figueiredo PC,et al.Light-NBI to identify high-risk phenotypes for gastric adenocarcinoma:do we still need biopsies?[J]Scand J Gastroenterol,2016,51:501-506.
[24]Dutta AK,Sajith KG,Pulimood AB,et al.Narrow band imaging versus white light gastroscopy in detecting potentially premalignant gastric lesions:a randomized prospective crossover study[J].Indian J Gastroenterol,2013,32:37-42.
[25]Uedo N,Ishihara R,Iishi H,et al.A new method of diagnosing gastric intestinal metaplasia:narrow-band imaging with magnifying endoscopy[J].Endoscopy,2006,38:819-824.
[26]Savarino E,Corbo M,Dulbecco P,et al.Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia[J].World J Gastroenterol,2013,19:2668-2675.
[27]Rerknimitr R,Imraporn B,Klaikeaw N,et al.Non-sequential narrow band imaging for targeted biopsy and monitoring of gastric intestinal metaplasia[J].World J Gastroenterol,2011,17:1336-1342.
[28]Wang L,Huang W,Du J,et al.Diagnostic yield of the light blue crest sign in gastric intestinal metaplasia:a meta-analysis[J].PLoS One,2014,9:e92874.
[29]Doyama H,Yoshida N,Tsuyama S,et al.The “white globe appearance”(WGA):a novel marker for a correct diagnosis of early gastric cancer by magnifying endoscopy with narrowband imaging (M-NBI)[J].Endosc Int Open,2015,3:120- 124.
[30]Kanemitsu T,Yao K,Nagahama T,et al.The vessels within epithelial circle (VEC) pattern as visualized by magnifying endoscopy with narrow-band imaging (ME-NBI) is a useful marker for the diagnosis of papillary adenocarcinoma:a case-controlled study[J].Gastric Cancer,2014,17:469-77.
[31]Ye L,Xiao X,Zhu L.The Comparison of Etomidate and Propofol Anesthesia in Patients Undergoing Gastrointestinal Endoscopy:A Systematic Review and Meta-Analysis[J].Surg Laparosc Endosc Percutan Tech,2017,27:1-7.
[32]Chang YT,Tsai TC,Hsu H,et al.Sedation for gastrointestinal endoscopy with the application of target-controlled infusion[J].Turk J Gastroenterol,2015,26:417-422.(https://www.daowen.com)
[33]Chiang MH,Wu SC,You CH,et al.Target-controlled infusion vs.manually controlled infusion of propofol with alfentanil for bidirectional endoscopy:a randomized controlled trial[J].Endoscopy,2013,45:907-914.
[34]Dumonceau JM,Riphaus A,Schreiber F,et al.Non-anesthesiologist administration of propofol for gastrointestinal endoscopy:European Society of Gastrointestinal Endoscopy,European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline-Updated June 2015[J].Endoscopy,2015,47:1175-1189.
[35]Dumonceau JM,Riphaus A,Aparicio JR,et al.European Society of Gastrointestinal Endoscopy,European Society of Gastroenterology and Endoscopy Nurses and Associates,and the European Society of Anaesthesiology Guideline:Non-anesthesiologist administration of propofol for GI endoscopy[J].Endoscopy,2010,42:960-974.
[36]Kono Y,Takenaka R,Kawahara Y,et al.Chromoendoscopy of gastric adenoma using an acetic acid indigocarmine mixture[J].World J Gastroenterol,2014,20:5092-5097.
[37]Mouri R,Yoshida S,Tanaka S,et al.Evaluation and validation of computed virtual chromoendoscopy in early gastric cancer[J].Gastrointest Endosc,2009,69(6):1052-1058.
[38]Kida M,Kobayashi K,Saigenji K.Routine chromoendoscopy for gastrointestinal diseases:indications revised[J].Endoscopy,2003,35:590-596.
[39]Ida K,Hashimoto Y,Takeda S,et al.Endoscopic diagnosis of gastric cancer with dye scattering[J].Am J Gastroenterol,1975,63:316-320.
[40]Canto MI.Staining in gastrointestinal endoscopy:the basics[J].Endoscopy,1999,31:479-486.
[41]Adachi Y,Shiraishi N,Kitano S.Modern treatment of early gastric cancer:review of the Japanese experience[J].Dig Surg,2002,19:333-339.
[42]Fujishiro M.Endoscopic submucosal dissection for stomach neoplasms[J].World J Gastroenterol,2006,12:5108-5112.
[43]Tsunada S,Ogata S,Mannen K,et al.Case series of endoscopic balloon dilation to treat a stricture caused by circumferential resection of the gastric antrum by endoscopic submucosal dissection[J].Gastrointest Endosc,2008,67:979-983.
[44]Coda S,Oda I,Gotoda T,et al.Risk factors for cardiac and pyloric stenosis after endoscopic submucosal dissection,and efficacy of endoscopic balloon dilation treatment[J].Endoscopy,2009,41:421-426.
[45]Draganov PV,Wang AY,Othman MO,et al.AGA Institute clinical practice update:endoscopic submucosal dissection in the United States[J].Clin Gastroenterol Hepatol,2019,17(1):16-25.
[46]Hwang JH,et al.Endoscopic mucosal resection[J].Gastrointest Endosc,2015,82(2):215-226.
[47]Jung YS,Park DI.Submucosal injection solutions for endoscopic 581 mucosal resection and endoscopic submucosal dissection of gastrointestinal neoplasms[J].Gastrointestinal Intervention,2013,2(2):73-77.
[48]Hatta W,Gotoda T,Oyama T,et al.A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer:“eCura system”[J].Am J Gastroenterol,2017,112 (6):874-881.
[49]Suzuki H,Oda I,Abe S,et al.Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series[J].Gastric Cancer,2017,20(4):679-689.
[50]Suzuki H,Takizawa K,Hirasawa T,et al.Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection:'Real-world evidence' in Japan[J].Dig Endosc,2019,31(1):30-39.
[51]Kawata N,Kakushima N,Takizawa K,et al.Risk factors for lymph node metastasis and longterm outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection[J].Surg Endosc,2017,31(4):1607-1616.
[52]Kikuchi S,Kuroda S,Nishizaki M,et al.Management of early gastric cancer that meet the indication for radical lymph node dissection following endoscopic resection:a retrospective ecohort analysis[J].BMC Surg,2017,17(1):72.
[53]Kim ER,Lee H,Min BH,et al.Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer[J].Br J Surg,2015,102(11):1394-1401.
[54]Yano T,Ishido K,Tanabe S,et al.Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection[J].Surg Endosc,2018,32(3):1314-1323.
[55]Ito H,Inoue H,Ikeda H,et al.Surgical outcomes and clinicopathological characteristics of patients who under wentpotentially noncurative endoscopic resection for gastric Chin J Gastrointestinal Endoscopy (Electronic Edition).a report of a single-center experience[J].Gastroenterol Res Pract,2013,427405.
[56]Hoteya S,Iizuka T,Kikuchi D,et al.Clinic opathological outcomes of patients with early gastric cancer after noncurative endoscopic submucosal dissection[J].Digestion,2016,93 (1):53-58.
[57]Sunagawa H,Kinoshita T,Kaito A,et al.Additional surgery for non-curative resection after endoscopic submucosal dissectionfor gastric cancer:a retrospective analysis of 200 cases[J].Surg Today,2017,47(2):202-209.
[58]Toyokawa T,Ohira M,Tanaka H,et al.Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer[J].Surg Endosc,2016,30(6):2404-2414.
[59]Yamanouchi K,Ogata S,Sakata Y,et al.Effect of additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer[J].Endosc Int Open,2016,4(1):E24-29.
[60]Jung DH,Huh CW,Kim JH,et al.Risk-stratification model based on lymph node metastasis after noncurative endoscopic resection for early gastric cancer[J].Ann Surg Oncol,2017,24 (6):1643-1649.
[61]Probst A,Schneider A,Schaller T,et al.Endoscopic submucosal dissection for early gastric cancer:are expanded resection criteria safe for Western patients?[J]Endoscopy,2017,49 (9):855-865.
[62]Kim HS,Ahn JY,Kim SO,et al.Can further gastrectomybe avoided in patients with incomplete endoscopic resection?[J]Surg Endosc,2017,31(11):4735-4748.
[63]Esaki M,Hatta W,Shimosegawa T,et al.Age affects clinical management after noncurative endoscopic submucosal dissection for early gastric cancer[J].Dig Dis,2019,37(6):423-433.
[64]Hatta W,Gotoda T,Oyama T,et al.Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer?[J]A comparative study Gastric Cancer,2018,21(3):481-489.